CHICKEN SOUP FOR THE SOUL EN (CSSE) Fundamental Analysis & Valuation

NASDAQ:CSSE • US16842Q1004

Current stock price

0.1055 USD
-0.01 (-10.21%)
At close:
0.054 USD
-0.05 (-48.82%)
After Hours:

This CSSE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. CSSE Profitability Analysis

1.1 Basic Checks

  • In the past year CSSE has reported negative net income.
  • CSSE had a negative operating cash flow in the past year.
  • In the past 5 years CSSE always reported negative net income.
  • In the past 5 years CSSE always reported negative operating cash flow.
CSSE Yearly Net Income VS EBIT VS OCF VS FCFCSSE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 -200M -400M -600M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -152.35%, CSSE is doing worse than 92.11% of the companies in the same industry.
Industry RankSector Rank
ROA -152.35%
ROE N/A
ROIC N/A
ROA(3y)-62.52%
ROA(5y)-47.4%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CSSE Yearly ROA, ROE, ROICCSSE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 100 -100 -150

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for CSSE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CSSE Yearly Profit, Operating, Gross MarginsCSSE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 100 -100 200 -200

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. CSSE Health Analysis

2.1 Basic Checks

  • CSSE does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for CSSE has been increased compared to 1 year ago.
  • Compared to 1 year ago, CSSE has a worse debt to assets ratio.
CSSE Yearly Shares OutstandingCSSE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
CSSE Yearly Total Debt VS Total AssetsCSSE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M

2.2 Solvency

  • Based on the Altman-Z score of -4.31, we must say that CSSE is in the distress zone and has some risk of bankruptcy.
  • CSSE's Altman-Z score of -4.31 is on the low side compared to the rest of the industry. CSSE is outperformed by 81.58% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -4.31
ROIC/WACCN/A
WACC1.09%
CSSE Yearly LT Debt VS Equity VS FCFCSSE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M 400M -400M

2.3 Liquidity

  • A Current Ratio of 0.53 indicates that CSSE may have some problems paying its short term obligations.
  • With a Current ratio value of 0.53, CSSE is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
  • CSSE has a Quick Ratio of 0.53. This is a bad value and indicates that CSSE is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.53, CSSE is doing worse than 72.37% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.53
Quick Ratio 0.53
CSSE Yearly Current Assets VS Current LiabilitesCSSE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. CSSE Growth Analysis

3.1 Past

  • CSSE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -151.68%.
  • The Revenue for CSSE has decreased by -36.32% in the past year. This is quite bad
  • The Revenue has been growing by 61.38% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-151.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.82%
Revenue 1Y (TTM)-36.32%
Revenue growth 3Y64.28%
Revenue growth 5Y61.38%
Sales Q2Q%-75%

3.2 Future

  • Based on estimates for the next years, CSSE will show a very strong growth in Earnings Per Share. The EPS will grow by 23.89% on average per year.
  • Based on estimates for the next years, CSSE will show a quite strong growth in Revenue. The Revenue will grow by 10.04% on average per year.
EPS Next Y42.18%
EPS Next 2Y62.8%
EPS Next 3Y39.86%
EPS Next 5Y23.89%
Revenue Next Year21.93%
Revenue Next 2Y18.06%
Revenue Next 3Y13.53%
Revenue Next 5Y10.04%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
CSSE Yearly Revenue VS EstimatesCSSE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M
CSSE Yearly EPS VS EstimatesCSSE Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 -2 4 -4 6 -6

More info and screens

Find the best growth stocksShow best growing peers

4

4. CSSE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CSSE. In the last year negative earnings were reported.
  • The Price/Forward Earnings ratio is 0.03, which indicates a rather cheap valuation of CSSE.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CSSE indicates a rather cheap valuation: CSSE is cheaper than 100.00% of the companies listed in the same industry.
  • CSSE's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.28.
Industry RankSector Rank
PE N/A
Fwd PE 0.03
CSSE Price Earnings VS Forward Price EarningsCSSE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CSSE Per share dataCSSE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -10 -20

4.3 Compensation for Growth

  • CSSE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • CSSE's earnings are expected to grow with 39.86% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y62.8%
EPS Next 3Y39.86%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CSSE Dividend Analysis

5.1 Amount

  • CSSE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

CSSE Fundamentals: All Metrics, Ratios and Statistics

CHICKEN SOUP FOR THE SOUL EN

NASDAQ:CSSE (7/2/2024, 8:13:23 PM)

After market: 0.054 -0.05 (-48.82%)

0.1055

-0.01 (-10.21%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)05-13
Earnings (Next)08-12
Inst Owners0.05%
Inst Owner Change0%
Ins Owners3.12%
Ins Owner Change0%
Market Cap3.42M
Revenue(TTM)212.19M
Net Income(TTM)-630.84M
Analysts43.33
Price Target2.81 (2563.51%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.51
Dividend Growth(5Y)-0.36%
DP-1.69%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-72.95%
Min Revenue beat(2)-76.17%
Max Revenue beat(2)-69.74%
Revenue beat(4)0
Avg Revenue beat(4)-54.39%
Min Revenue beat(4)-76.17%
Max Revenue beat(4)-34.76%
Revenue beat(8)2
Avg Revenue beat(8)-23.46%
Revenue beat(12)2
Avg Revenue beat(12)-17.11%
Revenue beat(16)5
Avg Revenue beat(16)-11.51%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 0.03
P/S 0.02
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-20.06
EYN/A
EPS(NY)3.96
Fwd EY3751.28%
FCF(TTM)-0.45
FCFYN/A
OCF(TTM)-0.24
OCFYN/A
SpS6.54
BVpS-17.12
TBVpS-24.02
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -152.35%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-62.52%
ROA(5y)-47.4%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 6.79%
Cap/Sales 3.26%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.53
Quick Ratio 0.53
Altman-Z -4.31
F-Score2
WACC1.09%
ROIC/WACCN/A
Cap/Depr(3y)4.58%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.01%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-151.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.82%
EPS Next Y42.18%
EPS Next 2Y62.8%
EPS Next 3Y39.86%
EPS Next 5Y23.89%
Revenue 1Y (TTM)-36.32%
Revenue growth 3Y64.28%
Revenue growth 5Y61.38%
Sales Q2Q%-75%
Revenue Next Year21.93%
Revenue Next 2Y18.06%
Revenue Next 3Y13.53%
Revenue Next 5Y10.04%
EBIT growth 1Y-31.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year224.06%
EBIT Next 3Y56.56%
EBIT Next 5Y32.71%
FCF growth 1Y60.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y77.99%
OCF growth 3YN/A
OCF growth 5YN/A

CHICKEN SOUP FOR THE SOUL EN / CSSE Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for CHICKEN SOUP FOR THE SOUL EN?

ChartMill assigns a fundamental rating of 2 / 10 to CSSE.


What is the valuation status for CSSE stock?

ChartMill assigns a valuation rating of 4 / 10 to CHICKEN SOUP FOR THE SOUL EN (CSSE). This can be considered as Fairly Valued.


How profitable is CHICKEN SOUP FOR THE SOUL EN (CSSE) stock?

CHICKEN SOUP FOR THE SOUL EN (CSSE) has a profitability rating of 0 / 10.


What is the earnings growth outlook for CHICKEN SOUP FOR THE SOUL EN?

The Earnings per Share (EPS) of CHICKEN SOUP FOR THE SOUL EN (CSSE) is expected to grow by 42.18% in the next year.